4-Methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione

4-Methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione Suppliers list
Company Name: Quality Control Solutions Ltd.  
Tel: 0755-66853366 13670046396
Email: orders@qcsrm.com
Company Name: Nanjing XiZe Biotechnology CO., Ltd.  
Tel: 025-66023220 15250997978
Email: 1511893459@qq.com
Company Name: Nanjing ERan Biological Pharmaceutical Co., Ltd.  
Tel: 13770809694
Email: googlexu_0114@sina.com
Company Name: Zhengzhou Guancheng Laboratory equipment Sales  
Tel: 0371-88888888 qq272369594;2159423853qq
Email: 2723695949@qq.com
Company Name: Zhengzhou Acme Chemical Co., Ltd.  
Tel: 0371-0371-55629727 13323845623
Email: 2885676761@qq.com
4-Methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione Basic information
Product Name:4-Methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione
Synonyms:4-methyl-1,3-dihydro-1,4-benzodiazepine-2,5-dione;1H-1,4-Benzodiazepine-2,5-dione,3,4-dihydro-4-methyl-;4-Methyl-3,4-dihydrobenzo[e][1,4]diazepine-2,5-dione;4-Methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione
CAS:3415-35-8
MF:C10H10N2O2
MW:190.2
EINECS:
Product Categories:
Mol File:3415-35-8.mol
4-Methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione Structure
4-Methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione Chemical Properties
Melting point 223-226 °C(Solv: ethanol (64-17-5))
Boiling point 430.7±38.0 °C(Predicted)
density 1.234±0.06 g/cm3(Predicted)
pka13.20±0.20(Predicted)
Safety Information
HazardClass IRRITANT
MSDS Information
4-Methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione Usage And Synthesis
Uses3,4-Dihydro-4-methyl-1H-1,4-benzodiazepine-2,5-dione is used as a reactant in the synthetic preparation and cyclopropanation of 3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-diones.
4-Methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione Preparation Products And Raw materials
Preparation Products7-Bromo-4-methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione
Tag:4-Methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione(3415-35-8) Related Product Information
7,8-Dimethoxy-1,2,3,11a-tetrahydro-10H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-5,11-dione 7-Bromo-4-methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione (2S,11aS)-Fmoc-2-amino-10-carboxymethyl-1,2,3,11a-tetrahydro-10H-pyrrolo[2,1-c][1,4]-benzodiazepine-5,11-dione 4-Methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione (S)-(+)-2,3-Dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione 3,4-Dihydro-1H-benzo[e][1,4]diazepine-2,5-dione (2R,11aS)-2-Hydroxy-1,2,3,11a-tetrahydro-10H-pyrrolo[2,1-c][1,4]-benzodiazepine-5,11-dione 7-Iodo-5,11-dioxotriazadibenzo[a,d]cycloheptene-2-carboxylic acid t-butyl ester 7-Fluoro-3,4-dihydro-4-methyl-1H-1,4-benzodiazepine-2,5-dione 1,3,4,12a-tetrahydropyrazino[2,1-c][1,4]benzodiazepine-6,12(2H,11H)-dione (11aS)-2-amino-2,3-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione SALOR-INT L308455-1EA (11aS)-2-amino-10-methyl-2,3-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione 11-methyl-1,3,4,12a-tetrahydropyrazino[2,1-c][1,4]benzodiazepine-6,12(2H,11H)-dione